GLP-1 Revolution: From diabetes to weight loss and beyond.
Join Dr. Ted Feldman, Chief Medical Officer at Rightway, and Kristin Devlin, Senior VP of Pharmacy, as they unpack GLP-1 drugs — a groundbreaking class of medicines reshaping treatment for diabetes, obesity, and cardiometabolic disease.
In this episode, they explain:
- How GLP-1s work and why they’re generating so much attention.
- Who may benefit most from these therapies.
- Practical considerations like safety, access, and adherence.
- How Rightway supports members with benefit navigation, manufacturer programs, and cost-saving strategies.
Listen to the podcast.








